Skip to main content

Rheumatoid Arthritis Excellence Forum

Commentary
By A. Mark Fendrick, MD, University of Michigan, School of Public Health A. Mark Fendrick, MD, director at the University of Michigan Center for Value-Based Insurance Design, weighs the pros and cons of patient support programs, focusing on value-based…
Interview
By Julie Gould Peter M ten Klooster, PhD, assistant professor at the University of Twente in Enschede in the Netherlands, discusses the importance of achieving early remission for patients with rheumatoid arthritis (RA). He highlights the major takeaways…
Interview
By Julie Gould  Beau Norgeot, MS, of Bakar Computational Health Sciences Institute at the University of California, explains how artificial intelligence (AI) impacts the cost of care for patients with complex diseases, including rheumatoid arthritis, and…
Interview
By Julie Gould Parvaneh Heidari, PhD student at Monash University, explains why it is recommended that health policy makers globally identify the appropriate out-of-pocket amount, so these costs do not affect medication adherence among patients with…
Interview
By: Julie Gould  Kaleb Michaud, PhD, and Elizabeth Mollard, PhD, both from the University of Nebraska Medical Center, recently spoke with us and explained why the use of mobile applications among patients with rheumatoid arthritis have the potential to…
Interview
Nirav Shah, MD, is an attending anesthesiologist and interventional pain management specialist at Northshore University Health System and a clinician educator at the University of Chicago in Illinois. During this interview, Dr Shah discusses neuromodulation…
Interview
By Julie Gould According to recent study findings published online in Arthritis & Rheumatology, higher levels of physical activity reduced the risk of rheumatoid arthritis (RA).    In order to evaluate long-term physical activity and subsequent risk for…
Interview
According to the findings of a recent study, patients with rheumatoid arthritis (RA) and COPD that are treated with abatacept are not at an increased risk of adverse respiratory events compared with patients treated with other biologic DMARDs [bDMARDs].   “…
Interview
The use of rapid, cloud-enabled, onsite testing for rheumatoid arthritis (RA) has great potential to generate value to payers and lower the number of office visits for the average patient, according to recent research published online in the Journal of…
Interview
Wendy Marder, MD, an associate professor and clinical service chief of the division of rheumatology at Michigan Medicine in Ann Arbor, Michigan, discusses telemedicine in a rheumatology setting. Telemedicine has given physicians the ability to deliver care…
Back to Top